What’s Needed

Millions of Americans are pursuing relief through cannabinoids, almost all without access to clinically responsible use guidance and products. So we devised a new approach, with the right ingredients.
Clinical Experience

Our clinical leadership team blends deep experience in supportive oncology, geriatric pharmacy and cannabinoid-based care.

Their experience, their research, their data and their insights provided the foundation upon which EO has been built. And they continue drive and improve our performance every day.

Care That Scales

Our digital health platform provides clinically responsible, personalized, adaptive product dose and use guidance - while generating valuable efficacy and cost of care data.

And it does so at low/no cost. So every American can access the guidance they need to use cannabinoids more safely and effectively.

Medicalized Products

Our federally legal products are clinician designed, precision dosed and available only in healthier, non-combustible forms.Our  blends deep experience in supportive oncology, geriatric pharmacy and cannabinoid-based care.

All our products are made from 100% organic hemp, are 3rd-party tested and are produced at GMP-certified facilities.

Clinical Efficacy

Cancer and treatment-related symptom intensity for EO care plan users as measured over time using broadly accepted PROMIS metrics. 50 is healthy adult baseline.

*3-point or greater reduction in PROMIS score. The data is sourced from over 100 cancer patients and older adults who utilized EO’s clinical care platform to manage their symptoms. PROMIS scores and activity difficulty levels were documented before beginning care and periodically throughout treatment to assess symptom changes. ER visits and any side effects were also monitored during the course of treatment, as well as any patient-reported reduction in prescription medications.

Cost of Care Impacts

Cancer patients using EO care plans reported fewer emergency room visits and reduced reliance on prescription medications.

$23,169

Estimated per patient annual cost of cancer symptom management.

$11,078

Estimated per patient annual cost of cancer symptom management with EO.

*The data is sourced from over 100 cancer patients and older adults who utilized EO’s clinical care platform to manage their symptoms. PROMIS scores and activity difficulty levels were documented before beginning care and periodically throughout treatment to assess symptom changes. ER visits and any side effects were also monitored during the course of treatment, as well as any patient-reported reduction in prescription medications.

Tech That Enables

All the input and feedback you provide is securely analyzed by our proprietary data model which then generates draft care plans and insights for our clinicians to review, edit, add to and approve.

This allows them to provide care that’s more informed by more patients like you, spend less time on administrative tasks and more time with you.

Responsible Products

All our products are federally legal, clinician designed, precision dosed and available only in healthier, non-combustible forms.

They are made from 100% organic hemp, are 3rd-party tested and are produced at GMP-certified facilities.

Clinical Leadership

CHIEF MEDICAL OFFICER

Brooke Worster, MD
“Cannabis can be a helpful tool in managing symptoms caused by cancer and its treatments. But too many patients don’t get the support they need to responsibly and optimally experience its benefits .”

CHIEF CANNABIS CLINICIAN

Ben Caplan, MD
“Cannabis is powerful medicine and comes with real benefits and risks. With more than 10 years advising thousands of patients, I know the right, ongoing guidance can make all the difference.”

GERIATRIC CLINICAL PHARMACIST

Emily Hajjar, PharmD, BCGP

CHIEF MEDICAL OFFICER

Brooke Worster, MD

A pioneering palliative care clinician and researcher, Dr. Worster is currently Director, Supportive Oncology at Jefferson Health in Philadelphia. She is a graduate of Temple University School of Medicine and completed her fellowship in palliative care and pain management at MGH Brigham and Dana Farber Cancer Center in Boston.

Read More

CHIEF CANNABIS CLINICIAN

Ben Caplan, MD

An internationally recognized cannabis clinician and educator, Dr. Caplan has overseen the care of over 18,000 cannabis patients and developed protocols that have benefited tens of thousands more. He is a graduate of Tufts University School of Medicine and completed his residency in family medicine at Boston Medical Center.

Read More

GERIATRIC CLINICAL PHARMACIST

Emily Hajjar, PharmD, BCGP

A leading clinical geriatric pharmacist and educator, Dr. Hajjar serves as Professor and Director of the Population Health Pharmacy Program at the Jefferson College of Pharmacy. She received her PharmD at Duquesne University and completed a fellowship in Geriatric Pharmacoepidemiology at the University of Minnesota.

Read More

Clinical Advisors

Clinical Advisor

Regina Benjamin, MD

Clinical Advisor

Jacob Strand, MD

Clinical Advisor

Greg Garber, MSW, LCSW

Founding Team

CEO

Sean Collins

CXO

Dave Batista

Senior Data Modeler

Kristen Parton

MD / CCC

Ben Caplan

Project Manager

Camila O'Brien

Head of Products

Nial Demena

Board Members & Advisors

Board Member

Bill Van Faasen

Board Member

Steve Hoffman

Board Member

John Bridge

Board Member

Pete Sandore

Board Member

Robert Garber

Advisor

Kristi Savacool

Advisor

Brent Bannerman

Advisor

Maureen Sullivan

Advisor

Blake Zenger